Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19

Highlights

• 1.
  Acute phase SARS-CoV-2-specific T cells display an activated cytotoxic phenotype
• 2.
  Broad and polyfunctional SARS-CoV-2-specific T cell responses in convalescent phase
• 3.
  Detection of SARS-CoV-2-specific T cell responses also in seronegative individuals
• https://www.cell.com/cell/fulltext/S0092-8674(20)31008-4